Triamcinolone

General Toxicity Notes
May aggravate azotemia, Na+ retention, glucose intolerance, hypertension.
Excreted Unchanged %
No data
Half-Life (Normalesrd) Hours
1.9-6.0/Unchanged
Plasma Protein Binding %
No data
Volume Of Distribution L/Kg
1.4-2.1
Dose For Normal Renal Function
4-48 mg q24h
Adjustment For Renal Failure Method
D
Adjustment For Renal Failure Gfr, Ml/Min >50 [Recommended Level]
100% [B]
Adjustment For Renal Failure Gfr, Ml/Min 10-50 [Recommended Level]
100% [A]
Adjustment For Renal Failure Gfr, Ml/Min <10 [Recommended Level]
100% [B]
Supplement For Dialysis [Recommendation Level]: Ihd
IHD: None, [D]
Supplement For Dialysis [Recommendation Level]: Pd
PD: None, [D]
Supplement For Dialysis [Recommendation Level]: Crrt
CRRT: 100%, [D]
References
M&#246; llmann H, Rohdewald P, Schmidt EW, Salomon V, Derendorf H. Pharmacokinetics of triamcinolone acetonide and its phosphate ester. Eur J Clin Pharmacol. 1985; 29: 85-9. [PMID: 4054209]